RPTX
USDRepare Therapeutics Inc. Common Shares
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$1.820
High
$1.855
Low
$1.780
Volume
0.15M
Company Fundamentals
Market Cap
76.5M
Industry
Biotechnology
Country
Canada
Trading Stats
Avg Volume
0.13M
Exchange
NMS
Currency
USD
52-Week Range
Related News
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.
HC Wainwright & Co. Maintains Buy on Repare Therapeutics, Lowers Price Target to $3
HC Wainwright & Co. analyst Robert Burns maintains Repare Therapeutics with a Buy and lowers the price target from $5 to $3.
Repare Therapeutics to Present Initial Data from Phase 1 LIONS Clinical Trial at 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Repare Therapeutics Inc. ("Repare" or the "Company") (NASDAQ:RPTX), a clinical-stage precision oncology company, today announced it will share initial topline safety, tolerability and early efficacy data from the Phase
Related Stocks
FTLF
FitLife Brands Inc.
PRQR
ProQR Therapeutics N.V. Ordinary Shares
ONMDW
OneMedNet Corp Warrant
BIPJ
Brookfield Infrastructure Corporation 7.250% Subordinated Notes due 2084
NVEI
Nuvei Corporation Subordinate Voting Shares
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.